Article Details
Retrieved on: 2024-05-01 22:22:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Demand for Shingrix and Arexvy fueled quarterly revenue totals that surpassed analyst expectations, though the company warned its numbers may ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here